HIGH-Q Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Pharmaceutical manufacturer · Karachi · Pakistan
Karachi pharmaceutical manufacturer with prescription, nutraceutical and related healthcare businesses and domestic and export operations.
HIGH-Q Pharmaceuticals products in Pakistan
HIGH-Q Pharmaceuticals has 211 medicine presentations registered in Pakistan under 68 brands, covering 61 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and CNS & mental health. Its brands with the most registered strengths and packs are Telmikyt-A (Telmisartan + Amlodipine), Telmikyt-H (Telmisartan + Hydrochlorothiazide), Ongene (Ondansetron) and Tensikyt (Bisoprolol fumarate). 210 products have an official DRAP price on MedInfoBase. See all 68 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Pharmaceutical manufacturer
- Address
- B-64, KDA-1, Karsaz Road, Karachi-75300, Pakistan · 75300
- Website
- highq.pk ↗
- Phone
- +92 21 34528152-3
- info@highq.pk
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where HIGH-Q Pharmaceuticals is priced against the market
202 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Amikaye | Amikacin | 500 mg | IM/IV injection | 1's | 014948 | PKR 511.08 | PKR 511.08/vial/unit | No comparator |
| Amlo-Q | Amlodipine | 5 mg | Tablet | 20's | 047242 | PKR 194.27 | PKR 9.71/tablet | 🔒 Pharma Pro |
| Amlo-Q | Amlodipine | 10 mg | Tablet | 20's | 047243 | PKR 268.27 | PKR 13.41/tablet | 🔒 Pharma Pro |
| Aprexo Rotacaps | Tiotropium | 18 mcg | Inhalation capsule | 6's | 085940 | PKR 206.05 | PKR 34.34/capsule | 🔒 Pharma Pro |
| Aremed | Anastrozole | 1 mg | Tablet | 28's | 062297 | PKR 10,360.59 | PKR 370.02/tablet | 🔒 Pharma Pro |
| Basovir | Sofosbuvir | 400 mg | Tablet | 28's | 089072 | PKR 11,708.49 | PKR 418.16/tablet | 🔒 Pharma Pro |
| Chlorokyt | Chloroquine | 250 mg | Tablet | 500's | 112809 | PKR 1,571.22 | PKR 3.14/tablet | 🔒 Pharma Pro |
| Chlorokyt | Chloroquine | 50 mg/5 mL | Syrup | 60ml | 112810 | PKR 29.97 | PKR 0.50/mL | 🔒 Pharma Pro |
| Choli-D | Cholecalciferol | 5 mg | Injection | 1's | 082216 | PKR 219.49 | PKR 219.49/vial/unit | 🔒 Pharma Pro |
| Choli-D | Cholecalciferol | 5 mg | Injection | 5's | 082216 | PKR 931.84 | PKR 186.37/vial/unit | 🔒 Pharma Pro |
| Covitol | Lopinavir + Ritonavir | 200 mg + 50 mg | Tablet | 120's | 104474 | PKR 15,824.32 | PKR 131.87/tablet | 🔒 Pharma Pro |
| Covitol | Lopinavir + Ritonavir | 100 mg + 25 mg | Tablet | 120's | 112733 | PKR 8,536.06 | PKR 71.13/tablet | 🔒 Pharma Pro |
| Cycin | Ciprofloxacin | 100 mg/50 mL | IV infusion | 1's (50 ml) | 019467 | PKR 435.29 | — | No comparator |
| Cycin | Ciprofloxacin | 200 mg/100 mL | IV infusion | 1's | 019468 | PKR 1,069.57 | PKR 1,069.57/vial/unit | 🔒 Pharma Pro |
| Cycin | Ciprofloxacin | 500 mg | Tablet | 10's | 019522 | PKR 598.41 | PKR 59.84/tablet | 🔒 Pharma Pro |
| Cycin | Ciprofloxacin | 250 mg | Tablet | 10's | 019523 | PKR 350.67 | PKR 35.07/tablet | 🔒 Pharma Pro |
| Day Fort | Ceftazidime | 250 mg | Injection | 1's | 061171 | PKR 159.95 | PKR 159.95/vial/unit | 🔒 Pharma Pro |
| Day Fort | Ceftazidime | 500 mg | Injection | 1's | 061172 | PKR 243.30 | PKR 243.30/vial/unit | 🔒 Pharma Pro |
| Day Fort | Ceftazidime | 1 g | Injection | 1's | 061173 | PKR 456.99 | PKR 456.99/vial/unit | 🔒 Pharma Pro |
| Dayfort Plus Injection 2.5gm (IV)Registry verified | Avibactam (as Sodium), Ceftazidime (as Pentahydrate) | — | — | — | 134992Official source ↗ | No indexed price | — | — |
| Dayline | Ceftriaxone | 250 mg | Injection | 1's | 061180 | PKR 186.87 | PKR 186.87/vial/unit | 🔒 Pharma Pro |
| Dayline | Ceftriaxone | 500 mg | Injection | 1's | 061181 | PKR 314.53 | PKR 314.53/vial/unit | 🔒 Pharma Pro |
| Dayline | Ceftriaxone | 1 g | Injection | 1's | 061182 | PKR 593.90 | PKR 593.90/vial/unit | 🔒 Pharma Pro |
| Dayline | Ceftriaxone | 250 mg | Injection | 1's | 083287 | PKR 186.87 | PKR 186.87/vial/unit | 🔒 Pharma Pro |
| Dayline | Ceftriaxone | 500 mg | Injection | 1's | 083288 | PKR 334.59 | PKR 334.59/vial/unit | 🔒 Pharma Pro |
| Dayline | Ceftriaxone | 2 g | IV injection | 1's | 100968 | PKR 885.66 | PKR 885.66/vial/unit | 🔒 Pharma Pro |
| Daypime 1gm InjectionRegistry verified | Cefepime as Hydrochloride with sterile arginine | — | — | — | 061175Official source ↗ | No indexed price | — | — |
| Daypime 500mg InjectionRegistry verified | Cefepime as Hydrochloride with sterile L-arginine | — | — | — | 061174Official source ↗ | No indexed price | — | — |
| Daypime Injection 2gm IM/IVRegistry verified | Cefepime (as Hydrochloride Monohydrate)(With L-Arginine) | — | — | — | 102989Official source ↗ | No indexed price | — | — |
| Daytaxime | Cefotaxime | 1 g | IV injection | 1's | 022648 | PKR 277.71 | PKR 277.71/vial/unit | 🔒 Pharma Pro |
| Daytaxime | Cefotaxime | 500 mg | Injection | 1's | 022649 | PKR 154.41 | PKR 154.41/vial/unit | 🔒 Pharma Pro |
| Daytaxime | Cefotaxime | 250 mg | Injection | 1's | 022650 | PKR 102.45 | PKR 102.45/vial/unit | 🔒 Pharma Pro |
| Dayzone | Ceftriaxone | 1 g | IM/IV injection | 1's | 022646 | PKR 883.61 | PKR 883.61/vial/unit | No comparator |
| Dayzone | Ceftriaxone | 250 mg | IV/IM injection | 1's | 022647 | PKR 261.59 | PKR 261.59/vial/unit | No comparator |
| Dexokyt Capsule 30mgRegistry verified | Dexlansoprazole Dual Delayed Release Pellets Eq. to Dexlansoprazole | — | — | — | 112808Official source ↗ | No indexed price | — | — |
| Dexokyt DDR Capsule 60mgRegistry verified | Dexlansoprazole Dual Delayed Release Pellets Eq. to Dexlansoprazole | — | — | — | 112802Official source ↗ | No indexed price | — | — |
| Dormex | Midazolam | 7.5 mg | Tablet | 1x10's | 053329 | PKR 92.51 | PKR 9.25/tablet | 🔒 Pharma Pro |
| Drezil | Fluoxetine | 20 mg | Capsule | 1x10's | 044188 | PKR 120.26 | PKR 12.03/capsule | 🔒 Pharma Pro |
| Em-flox | Moxifloxacin | 200 mg | Tablet | 1x10's | 055993 | PKR 416.27 | PKR 41.63/tablet | 🔒 Pharma Pro |
| Em-flox | Moxifloxacin | 400 mg | Tablet | 1x5's | 055994 | PKR 878.83 | PKR 175.77/tablet | 🔒 Pharma Pro |
| Empagli | Empagliflozin | 25 mg | Tablet | 30's | 098696 | PKR 3,343.80 | PKR 111.46/tablet | 🔒 Pharma Pro |
| Empagli | Empagliflozin | 25 mg | Tablet | 14's | 098696 | PKR 1,592.09 | PKR 113.72/tablet | 🔒 Pharma Pro |
| Empagli | Empagliflozin | 25 mg | Tablet | 28's | 098696 | PKR 3,120.75 | PKR 111.46/tablet | 🔒 Pharma Pro |
| Empagli | Empagliflozin | 10 mg | Tablet | 30's | 098697 | PKR 2,793.33 | PKR 93.11/tablet | 🔒 Pharma Pro |
| Empagli | Empagliflozin | 10 mg | Tablet | 14's | 098697 | PKR 1,330.15 | PKR 95.01/tablet | 🔒 Pharma Pro |
| Empagli | Empagliflozin | 10 mg | Tablet | 28's | 098697 | PKR 2,607.10 | PKR 93.11/tablet | 🔒 Pharma Pro |
| Enqo | Entecavir | 1 mg | Tablet | 30's | 088899 | PKR 20,591.34 | PKR 686.38/tablet | 🔒 Pharma Pro |
| Enqo | Entecavir | 0.5 mg | Tablet | 30's | 088900 | PKR 12,355.19 | PKR 411.84/tablet | 🔒 Pharma Pro |
| Eskem 20mg CapsulesRegistry verified | Enteric coated pellets of Esomeprazole Magnesium Trihydrate eq. to Esomeprazole | — | — | — | 044309Official source ↗ | No indexed price | — | — |
| Eskem 40mg CapsulesRegistry verified | Enteric coated pellets of Esomeprazole Magnesium Trihydrate eq. to Esomeprazole | — | — | — | 044310Official source ↗ | No indexed price | — | — |
All 68 HIGH-Q Pharmaceuticals brands in Pakistan
- Amikaye Amikacin · 500 mg injection
- Amlo-Q Amlodipine · 10 mg tablet, 5 mg tablet
- Aprexo Rotacaps Tiotropium · 18 mcg inhalation
- Aremed Anastrozole · 1 mg tablet
- Basovir Sofosbuvir · 400 mg tablet
- Chlorokyt Chloroquine · 250 mg tablet, 50 mg/5 mL syrup
- Choli-D Cholecalciferol · 5 mg injection
- Covitol Lopinavir + Ritonavir · 100 mg + 25 mg tablet, 200 mg + 50 mg tablet
- Cycin Ciprofloxacin · 100 mg/50 mL infusion, 200 mg/100 mL infusion, 250 mg tablet
- Day Fort Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
- Dayline Ceftriaxone · 1 g injection, 2 g injection, 250 mg injection
- Daytaxime Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
- Dayzone Ceftriaxone · 1 g injection, 250 mg injection
- Dormex Midazolam · 7.5 mg tablet
- Drezil Fluoxetine · 20 mg capsule
- Em-flox Moxifloxacin · 200 mg tablet, 400 mg tablet
- Empagli Empagliflozin · 10 mg tablet, 25 mg tablet
- Enqo Entecavir · 0.5 mg tablet, 1 mg tablet
- Filokyt Sulfasalazine · 500 mg tablet
- Getrital Carbamazepine · 100 mg/5 mL suspension, 200 mg tablet
- Hizone Ceftriaxone · 1 g injection, 250 mg injection
- Hydrokyte Hydroxychloroquine · 200 mg tablet
- Ibuzolin Ibuprofen · 100 mg/5 mL suspension, 200 mg tablet, 200 mg/5 mL suspension
- Iokrin Potassium iodide · 130 mg tablet, 65 mg tablet
- Itrasilin Itraconazole · 100 mg capsule
- Jardin Loratadine · 10 mg tablet
- Jaytaxime Cefotaxime · 1 g injection, 2 g injection, 250 mg injection
- Kanovis Ascorbic acid · 500 mg tablet
- Lamikeu Lamivudine · 100 mg tablet
- Lcyn Levofloxacin · 250 mg tablet, 500 mg tablet, 750 mg tablet
- Letocor Letrozole · 2.5 mg tablet
- Levixa Levetiracetam · 100 mg/mL solution, 750 mg tablet
- Levixa XR Levetiracetam · 500 mg tablet
- Meclokyt Metoclopramide · 10 mg tablet, 5 mg/5 mL syrup
- Meroque Meropenem · 1 g injection, 500 mg injection
- Miprofec Misoprostol · 200 mcg tablet
- Mixel Cefixime · 100 mg/5 mL suspension, 200 mg capsule, 200 mg/5 mL suspension
- One-3 Artemether + Lumefantrine · 20 mg + 120 mg tablet, 40 mg + 240 mg tablet, 80 mg + 480 mg tablet
- Ongene Ondansetron · 4 mg tablet, 4 mg/5 mL syrup, 8 mg tablet
- Oslem Oseltamivir · 75 mg capsule
- OVA-MIT Clomifene citrate · 50 mg tablet
- Ova-rim Clomifene citrate · 50 mg tablet
- Padexol Paclitaxel (albumin-bound nanoparticles) · 100 mg injection, 30 mg injection
- Pedi-ORS Sodium chloride · 2.6 g sachet
- Platlo Clopidogrel · 75 mg tablet
- Pyloclar Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/5 mL suspension
- Qsartan Losartan · 25 mg tablet, 50 mg tablet
- Qupron Ciprofloxacin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/5 mL suspension
- Rekyt Quetiapine · 100 mg tablet, 25 mg tablet, 300 mg tablet
- Rekyt XR Quetiapine · 150 mg tablet, 200 mg tablet, 300 mg tablet
- Revirin-C Ribavirin · 100 mg capsule, 200 mg capsule, 400 mg tablet
- Rislet Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
- Ruling Omeprazole · 10 mg capsule, 20 mg capsule, 40 mg injection
- Simkeu Simvastatin · 10 mg tablet, 20 mg tablet
- Tavalose Lactulose · 3.35 g/5 mL suspension
- Telmikyt-A Telmisartan + Amlodipine · 40 mg + 10 mg tablet, 40 mg + 5 mg tablet, 80 mg + 10 mg tablet
- Telmikyt-H Telmisartan + Hydrochlorothiazide · 40 mg + 12.5 mg tablet, 80 mg + 12.5 mg tablet
- Tenere Tenofovir disoproxil · 300 mg tablet
- Tensikyt Bisoprolol fumarate · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
- Trignine Lamotrigine = · 100 mg tablet, 25 mg tablet, 50 mg tablet
- Verico Voriconazole · 200 mg tablet, 50 mg tablet
- Vesoft Sofosbuvir + Velpatasvir · 400 mg + 100 mg tablet
- Vomion Aprepitant · 125 mg capsule, 40 mg capsule, 80 mg capsule
- Xetron Ranitidine · 150 mg tablet, 300 mg tablet
- Zinkley Zinc sulfate · 20 mg tablet
- Zolixa Fluconazole · 150 mg capsule, 200 mg capsule, 50 mg capsule
- Zolki Linezolid · 100 mg/5 mL suspension, 400 mg tablet, 600 mg tablet
- Zyto Azithromycin · 200 mg/5 mL suspension, 250 mg tablet, 250 mg capsule
HIGH-Q Pharmaceuticals: common questions
How many products does HIGH-Q Pharmaceuticals have in Pakistan?
HIGH-Q Pharmaceuticals has 211 registered medicine presentations in Pakistan, sold under 68 brands and covering 61 generic medicines.
What are the main brands of HIGH-Q Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Telmikyt-A (Telmisartan + Amlodipine), Telmikyt-H (Telmisartan + Hydrochlorothiazide), Ongene (Ondansetron), Tensikyt (Bisoprolol fumarate) and Zyto (Azithromycin). This is not a sales ranking.
Which therapy areas does HIGH-Q Pharmaceuticals cover?
The most products are in Anti-infectives (87), Cardiovascular (45), CNS & mental health (26), Gastrointestinal & hepatology (22) and Endocrine & metabolic (6).
Where can I see HIGH-Q Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.